Literature DB >> 25260632

Interactions between beta-2 adrenoceptor gene variation, cardiovascular control and dietary sodium in healthy young adults.

John H Eisenach1, Darrell R Schroeder2, Emily S Pavey2, Alan R Penheiter3, Jean N Knutson4, Stephen T Turner5, Michael J Joyner4.   

Abstract

Dietary sodium affects function of the beta-2 adrenoceptor (ADRB2). We tested the hypothesis that haplotype variation in the ADRB2 gene would influence the cardiovascular and regional vasodilator responses to sympathoexcitatory manoeuvres following low, normal and high sodium diets, and ADRB2-mediated forearm vasodilation in the high sodium condition. Seventy-one healthy young adults were grouped by double homozygous haplotypes: Arg16+Gln27 (n = 31), the rare Gly16+Gln27 (n = 10) and Gly16+Glu27 (n = 30). Using a randomized cross-over design, subjects were studied following 5 days of controlled low, normal and high sodium with 1 month or longer between diets (and low hormone phase of the menstrual cycle). All three visits utilized ECG and finger plethysmography for haemodynamic measures, and the high sodium visit included a brachial arterial catheter for forearm vasodilator responses to isoprenaline with plethysmography. Lymphocytes were sampled for ex vivo analysis of ADRB2 density and binding conformation. We found a main effect of haplotype on ADRB2 density (P = 0.03) with the Gly16+Glu27 haplotype having the greatest density (low, normal, high sodium: 12.9 ± 0.9, 13.5 ± 0.9 and 13.6 ± 0.8 fmol mg(-1) protein, respectively) and Arg16+Gln27 having the least (9.3 ± 0.6, 10.1 ± 0.5 and 10.3 ± 0.6  fmol mg(-1) protein, respectively), but there were no sodium or haplotype effects on receptor binding conformation. In the mental stress trial, there was a main effect of haplotype on cardiac output (P = 0.04), as Arg16+Gln27 had the lowest responses. Handgrip and forearm vasodilation yielded no haplotype differences, and no correlations were present for ADRB2 density and haemodynamics. Our findings support cell-based evidence that ADRB2 haplotype influences ADRB2 protein expression independent of dietary sodium, yet the haemodynamic consequences appear modest in healthy humans.
© 2014 The Authors. The Journal of Physiology © 2014 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25260632      PMCID: PMC4262335          DOI: 10.1113/jphysiol.2014.276469

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  Beta2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells.

Authors:  B Lipworth; G H Koppelman; A P Wheatley; I Le Jeune; W Coutie; H Meurs; H F Kauffman; D S Postma; I P Hall
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

Authors:  C M Drysdale; D W McGraw; C B Stack; J C Stephens; R S Judson; K Nandabalan; K Arnold; G Ruano; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

3.  The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.

Authors:  V Dishy; G G Sofowora; H G Xie; R B Kim; D W Byrne; C M Stein; A J Wood
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

4.  Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure.

Authors:  David M Kaye; Belinda Smirk; Carolyn Williams; Garry Jennings; Murray Esler; Dianne Holst
Journal:  Pharmacogenetics       Date:  2003-07

5.  The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise.

Authors:  John H Eisenach; Antonio M McGuire; Rachel M Schwingler; Stephen T Turner; Michael J Joyner
Journal:  Physiol Genomics       Date:  2004-02-13       Impact factor: 3.107

6.  The Arg16Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function.

Authors:  Weihong Tang; Richard B Devereux; Dalane W Kitzman; Michael A Province; Mark Leppert; Albert Oberman; Paul N Hopkins; Donna K Arnett
Journal:  Am J Hypertens       Date:  2003-11       Impact factor: 2.689

7.  Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol.

Authors:  R D Aarons; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

8.  Sodium kinetics in salt-sensitive and salt-resistant normotensive and hypertensive subjects.

Authors:  B Wedler; M E Brier; M Wiersbitzky; S Gruska; E Wolf; R Kallwellis; G R Aronoff; F C Luft
Journal:  J Hypertens       Date:  1992-07       Impact factor: 4.844

9.  Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans.

Authors:  Vesna D Garovic; Michael J Joyner; Niki M Dietz; Eric Boerwinkle; Stephen T Turner
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

10.  Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol.

Authors:  J Fraser; J Nadeau; D Robertson; A J Wood
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more
  5 in total

1.  Preserved β-adrenergic-mediated vasodilation in skeletal muscle of young adults with obesity despite shifts in cyclooxygenase and nitric oxide synthase.

Authors:  Jacqueline K Limberg; Rebecca E Johansson; Katrina J Carter; Garrett L Peltonen; John W Harrell; J Mikhail Kellawan; Marlowe W Eldridge; Joshua J Sebranek; Benjamin J Walker; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-05       Impact factor: 4.733

Review 2.  Adrenergic receptors gene polymorphisms and autonomic nervous control of heart and vascular tone.

Authors:  L Matušková; M Javorka
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

3.  β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase.

Authors:  Jacqueline K Limberg; Rebecca E Johansson; Garrett L Peltonen; John W Harrell; J Mikhail Kellawan; Marlowe W Eldridge; Joshua J Sebranek; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-08       Impact factor: 4.733

4.  CRISPR/Cas9-mediated generation and analysis of N terminus polymorphic models of β2AR in isogenic hPSC-derived cardiomyocytes.

Authors:  Alexander Kondrashov; Nurul A N Mohd Yusof; Alveera Hasan; Joëlle Goulding; Thusharika Kodagoda; Duc M Hoang; Nguyen T N Vo; Tony Melarangi; Nazanin Dolatshad; Julia Gorelik; Stephen J Hill; Sian E Harding; Chris Denning
Journal:  Mol Ther Methods Clin Dev       Date:  2020-10-27       Impact factor: 6.698

5.  Greater Beta-Adrenergic Receptor Mediated Vasodilation in Women Using Oral Contraceptives.

Authors:  Jacqueline K Limberg; Garrett L Peltonen; Rebecca E Johansson; John W Harrell; Jeremy M Kellawan; Marlowe W Eldridge; Joshua J Sebranek; Benjamin J Walker; William G Schrage
Journal:  Front Physiol       Date:  2016-06-08       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.